-
1
-
-
84875219908
-
Prevalence, correlates, comorbidity and severity of bipolar disorder: Results from the Singapore Mental Health Study
-
Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study. J Affect Disord. 2013;146(2):189-96.
-
(2013)
J Affect Disord
, vol.146
, Issue.2
, pp. 189-196
-
-
Subramaniam, M.1
Abdin, E.2
Vaingankar, J.A.3
Chong, S.A.4
-
2
-
-
77956262711
-
Symptoms and signs of the initial prodrome of bipolar disorder: A systematic review
-
Skjelstad DV, Malt UF, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: A systematic review. J Affect Disord. 2010;126(1-2):1-13.
-
(2010)
J Affect Disord
, vol.126
, Issue.1-2
, pp. 1-13
-
-
Skjelstad, D.V.1
Malt, U.F.2
Holte, A.3
-
3
-
-
58149280388
-
Assessment and treatment of suicide risk in bipolar disorders
-
Pompili M, Rihmer Z, Innamorati M, Lester D, Girardi P, Tatarelli R. Assessment and treatment of suicide risk in bipolar disorders. Expert Rev Neurother. 2009;9(1):109-36.
-
(2009)
Expert Rev Neurother
, vol.9
, Issue.1
, pp. 109-136
-
-
Pompili, M.1
Rihmer, Z.2
Innamorati, M.3
Lester, D.4
Girardi, P.5
Tatarelli, R.6
-
4
-
-
79953100305
-
Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder
-
Söderlund J, Olsson SK, Samuelsson M, Walther-Jallow L, Johansson C, Erhardt S, et al. Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder. Journal of Psychiatry & Neuroscience: JPN. 2011;36(2):114.
-
(2011)
Journal of Psychiatry & Neuroscience: JPN
, vol.36
, Issue.2
, pp. 114
-
-
Söderlund, J.1
Olsson, S.K.2
Samuelsson, M.3
Walther-Jallow, L.4
Johansson, C.5
Erhardt, S.6
-
5
-
-
0035062306
-
Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania
-
Tsai SYM, Yang YY, Kuo CJ, Chen CC, Leu SJC. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord. 2001;64(2):185-93.
-
(2001)
J Affect Disord
, vol.64
, Issue.2
, pp. 185-193
-
-
Tsai, S.Y.M.1
Yang, Y.Y.2
Kuo, C.J.3
Chen, C.C.4
Leu, S.J.C.5
-
6
-
-
72649084925
-
Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder
-
Brietzke E, Kauer-Sant'Anna M, Teixeira AL, Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder. Brain Behav Immun. 2009;23(8):1079-82.
-
(2009)
Brain Behav Immun
, vol.23
, Issue.8
, pp. 1079-1082
-
-
Brietzke, E.1
Kauer-SanT'Anna, M.2
Teixeira, A.L.3
Kapczinski, F.4
-
7
-
-
84873279865
-
The role of the innate immune system in psychiatric disorders
-
Jones KA, Thomsen C. The role of the innate immune system in psychiatric disorders. Molecular and Cellular Neuroscience. 2013;53:52-62.http://dx.doi.org/ 10.1016/j.mcn.2012.10.002
-
(2013)
Molecular and Cellular Neuroscience
, vol.53
, pp. 52-62
-
-
Jones, K.A.1
Thomsen, C.2
-
8
-
-
67349287008
-
Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
-
Brietzke E, Stertz L, Fernandes BS, Kauer-Sant'Anna M, Mascarenhas M, Escosteguy Vargas A, et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord. 2009;116(3):214-7.
-
(2009)
J Affect Disord
, vol.116
, Issue.3
, pp. 214-217
-
-
Brietzke, E.1
Stertz, L.2
Fernandes, B.S.3
Kauer-Sant'Anna, M.4
Mascarenhas, M.5
Escosteguy Vargas, A.6
-
9
-
-
35948958993
-
Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
-
DOI 10.1016/j.jad.2007.02.018, PII S0165032707000912
-
Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord. 2007;104(1):91-5. (Pubitemid 350064526)
-
(2007)
Journal of Affective Disorders
, vol.104
, Issue.1-3
, pp. 91-95
-
-
Kim, Y.-K.1
Jung, H.-G.2
Myint, A.-M.3
Kim, H.4
Park, S.-H.5
-
10
-
-
34247490138
-
Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder
-
DOI 10.1016/j.pnpbp.2007.02.018, PII S0278584607000772
-
Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(4):952-5. (Pubitemid 46660310)
-
(2007)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
, vol.31
, Issue.4
, pp. 952-955
-
-
Dickerson, F.1
Stallings, C.2
Origoni, A.3
Boronow, J.4
Yolken, R.5
-
11
-
-
31844457040
-
Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients
-
DOI 10.1016/j.jad.2005.11.015, PII S0165032705003484
-
O'Brien SM, Scully P, Scott LV, Dinan TG. Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord. 2006;90(2):263-7. (Pubitemid 43183536)
-
(2006)
Journal of Affective Disorders
, vol.90
, Issue.2-3
, pp. 263-267
-
-
O'Brien, S.M.1
Scully, P.2
Scott, L.V.3
Dinan, T.G.4
-
12
-
-
71849104196
-
The potential use of biomarkers as an adjunctive tool for staging bipolar disorder
-
Kapczinski F, Dias VV, Kauer-Sant'Anna M, Brietzke E, Vázquez GH, Vieta E, et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(8):1366-71.
-
(2009)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.33
, Issue.8
, pp. 1366-1371
-
-
Kapczinski, F.1
Dias, V.V.2
Kauer-Sant'Anna, M.3
Brietzke, E.4
Vázquez, G.H.5
Vieta, E.6
-
13
-
-
84858287588
-
Electroconvulsive therapy (ECT) in bipolar disorder: A narrative review of literature
-
Thirthalli J, Prasad MK, Gangadhar BN. Electroconvulsive therapy (ECT) in bipolar disorder: A narrative review of literature. Asian J Psychiatr. 2012;5(1):11-7.
-
(2012)
Asian J Psychiatr
, vol.5
, Issue.1
, pp. 11-17
-
-
Thirthalli, J.1
Prasad, M.K.2
Gangadhar, B.N.3
-
14
-
-
79851512805
-
New treatment guidelines for acute bipolar depression: A systematic review
-
Nivoli AMA, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, et al. New treatment guidelines for acute bipolar depression: A systematic review. J Affect Disord. 2011;129(1-3):14-26.
-
(2011)
J Affect Disord
, vol.129
, Issue.1-3
, pp. 14-26
-
-
Nivoli, A.M.A.1
Colom, F.2
Murru, A.3
Pacchiarotti, I.4
Castro-Loli, P.5
González-Pinto, A.6
-
15
-
-
84862229244
-
New treatment guidelines for acute bipolar mania: A critical review
-
Nivoli AMA, Murru A, Goikolea JM, Crespo JM, Montes JM, González-Pinto A, et al. New treatment guidelines for acute bipolar mania: A critical review. J Affect Disord. 2012;140(2):125-41.
-
(2012)
J Affect Disord
, vol.140
, Issue.2
, pp. 125-141
-
-
Nivoli, A.M.A.1
Murru, A.2
Goikolea, J.M.3
Crespo, J.M.4
Montes, J.M.5
González-Pinto, A.6
-
16
-
-
70249087363
-
Response to ECT in bipolar I, bipolar II and unipolar depression
-
Medda P, Perugi G, Zanello S, Ciuffa M, Cassano G. Response to ECT in bipolar I, bipolar II and unipolar depression. J Affect Disord. 2009;118(1-3):55.
-
(2009)
J Affect Disord
, vol.118
, Issue.1-3
, pp. 55
-
-
Medda, P.1
Perugi, G.2
Zanello, S.3
Ciuffa, M.4
Cassano, G.5
-
17
-
-
39149143316
-
Electroconvulsive therapy in the treatment of mixed states in bipolar disorder
-
Valentí M, Benabarre A, García-Amador M, Molina O, Bernardo M, Vieta E. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry. 2008;23(1):53-6.
-
(2008)
Eur Psychiatry
, vol.23
, Issue.1
, pp. 53-56
-
-
Valentí, M.1
Benabarre, A.2
García-Amador, M.3
Molina, O.4
Bernardo, M.5
Vieta, E.6
-
18
-
-
79958134275
-
Physical treatments for bipolar disorder: A review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques
-
Loo C, Katalinic N, Mitchell PB, Greenberg B. Physical treatments for bipolar disorder: A review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord. 2011;132(1):1-13.
-
(2011)
J Affect Disord
, vol.132
, Issue.1
, pp. 1-13
-
-
Loo, C.1
Katalinic, N.2
Mitchell, P.B.3
Greenberg, B.4
-
19
-
-
0346914336
-
Raised Plasma Levels of Tumor Necrosis Factor [alpha] in Patients with Depression: Normalization during Electroconvulsive Therapy
-
DOI 10.1097/00124509-200312000-00002
-
Hestad KA, Tønseth S, Støen CD, Ueland T, Aukrust P. Raised Plasma Levels of Tumor Necrosis Factor [alpha] in Patients With Depression: Normalization During Electroconvulsive Therapy. J ECT. 2003;19(4):183-8. (Pubitemid 38018294)
-
(2003)
Journal of ECT
, vol.19
, Issue.4
, pp. 183-188
-
-
Hestad, K.A.1
Tonseth, S.2
Stoen, C.D.3
Ueland, T.4
Aukrust, P.5
-
20
-
-
34248169336
-
Electroconvulsive therapy: A review of history, patient selection, technique, and medication management
-
DOI 10.1097/SMJ.0b013e318038fce0, PII 0000761120070500000013
-
Taylor S. Electroconvulsive therapy: a review of history, patient selection, technique, and medication management. South Med J. 2007;100(5):494-8. (Pubitemid 46707451)
-
(2007)
Southern Medical Journal
, vol.100
, Issue.5
, pp. 494-498
-
-
Taylor, S.1
-
21
-
-
79955916722
-
Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder
-
Fluitman SB, Heijnen CJ, Denys DAJP, Nolen WA, Balk FJ, Westenberg HGM. Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. J Affect Disord. 2011;131(1):388-92.
-
(2011)
J Affect Disord
, vol.131
, Issue.1
, pp. 388-392
-
-
Fluitman, S.B.1
Heijnen, C.J.2
Denys, D.A.J.P.3
Nolen, W.A.4
Balk, F.J.5
Westenberg, H.G.M.6
-
22
-
-
0036319011
-
Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage
-
Mastbergen S, Lafeber F, Bijlsma J. Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology (Oxford). 2002;41(7):801-8. (Pubitemid 34822964)
-
(2002)
Rheumatology
, vol.41
, Issue.7
, pp. 801-808
-
-
Mastbergen, S.C.1
Lafeber, F.P.J.G.2
Bijlsma, J.W.J.3
-
23
-
-
33845467526
-
Pharmacodynamic of cyclooxygenase inhibitors in humans
-
DOI 10.1016/j.prostaglandins.2006.05.019, PII S109888230600058X, Eicosanoid-Mediated Regulation of Vascular and Renal Function
-
Capone ML, Tacconelli S, Di Francesco L, Sacchetti A, Sciulli MG, Patrignani P. Pharmacodynamic of cyclooxygenase inhibitors in humans. Prostaglandins Other Lipid Mediat. 2007;82(1-4):85-94. (Pubitemid 44895440)
-
(2007)
Prostaglandins and Other Lipid Mediators
, vol.82
, Issue.1-4
, pp. 85-94
-
-
Capone, M.L.1
Tacconelli, S.2
Di, F.L.3
Sacchetti, A.4
Sciulli, M.G.5
Patrignani, P.6
-
24
-
-
84861460724
-
Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial
-
Fields C, Drye L, Vaidya V, Lyketsos C. Celecoxib or Naproxen Treatment Does Not Benefit Depressive Symptoms in Persons Age 70 and Older: Findings From a Randomized Controlled Trial. American Journal of Geriatric Psych. 2012;20(6):505.
-
(2012)
American Journal of Geriatric Psych
, vol.20
, Issue.6
, pp. 505
-
-
Fields, C.1
Drye, L.2
Vaidya, V.3
Lyketsos, C.4
-
25
-
-
33846620518
-
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
-
DOI 10.1016/j.schres.2006.11.016, PII S0920996406004956
-
Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B. Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial. Schizophr Res. 2007;90(1-3):179-85. (Pubitemid 46177578)
-
(2007)
Schizophrenia Research
, vol.90
, Issue.1-3
, pp. 179-185
-
-
Akhondzadeh, S.1
Tabatabaee, M.2
Amini, H.3
Ahmadi, A.S.A.4
Abbasi, S.H.5
Behnam, B.6
-
26
-
-
51249112989
-
Celecoxib inhibits 5-lipoxygenase
-
Maier TJ, Tausch L, Hoernig M, Coste O, Schmidt R, Angioni C, et al. Celecoxib inhibits 5-lipoxygenase. Biochem Pharmacol. 2008;76(7):862-72.
-
(2008)
Biochem Pharmacol
, vol.76
, Issue.7
, pp. 862-872
-
-
Maier, T.J.1
Tausch, L.2
Hoernig, M.3
Coste, O.4
Schmidt, R.5
Angioni, C.6
-
27
-
-
49149090886
-
Celecoxib potently inhibits TNFα-induced nuclear translocation and activation of NF-κB
-
Funakoshi-Tago M, Shimizu T, Tago K, Nakamura M, Itoh H, Sonoda Y, et al. Celecoxib potently inhibits TNFα-induced nuclear translocation and activation of NF-κB. Biochem Pharmacol. 2008;76(5):662-71.
-
(2008)
Biochem Pharmacol
, vol.76
, Issue.5
, pp. 662-671
-
-
Funakoshi-Tago, M.1
Shimizu, T.2
Tago, K.3
Nakamura, M.4
Itoh, H.5
Sonoda, Y.6
-
28
-
-
20444405296
-
Celecoxib augmentation of continuously Ill patients with schizophrenia
-
DOI 10.1016/j.biopsych.2005.02.024, PII S0006322305001897
-
Rapaport MH, Delrahim KK, Bresee CJ, Maddux RE, Ahmadpour O, Dolnak D. Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia. Biol Psychiatry. 2005;57(12):1594-6. (Pubitemid 40805391)
-
(2005)
Biological Psychiatry
, vol.57
, Issue.12
, pp. 1594-1596
-
-
Rapaport, M.H.1
Delrahim, K.K.2
Bresee, C.J.3
Maddux, R.E.4
Ahmadpour, O.5
Dolnak, D.6
-
29
-
-
77955050321
-
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
-
Müller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, et al. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res. 2010;121(1-3):118.
-
(2010)
Schizophr Res
, vol.121
, Issue.1-3
, pp. 118
-
-
Müller, N.1
Krause, D.2
Dehning, S.3
Musil, R.4
Schennach-Wolff, R.5
Obermeier, M.6
-
30
-
-
40549126636
-
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: A double-blind, randomized, placebo-controlled study
-
DOI 10.1002/hup.912
-
Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol. 2008;23(2):87-94. (Pubitemid 351359580)
-
(2008)
Human Psychopharmacology
, vol.23
, Issue.2
, pp. 87-94
-
-
Nery, F.G.1
Monkul, E.S.2
Hatch, J.P.3
Fonseca, M.4
Zunta-Soares, G.B.5
Frey, B.N.6
Bowden, C.L.7
Soares, J.C.8
-
31
-
-
80053446003
-
A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder
-
Sayyah M, Boostani H, Pakseresht S, Malayeri A. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Psychiatry Res. 2011;189(3):403-6.
-
(2011)
Psychiatry Res
, vol.189
, Issue.3
, pp. 403-406
-
-
Sayyah, M.1
Boostani, H.2
Pakseresht, S.3
Malayeri, A.4
-
32
-
-
67650083320
-
Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial
-
Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety. 2009;26(7):607-11.
-
(2009)
Depress Anxiety
, vol.26
, Issue.7
, pp. 607-611
-
-
Akhondzadeh, S.1
Jafari, S.2
Raisi, F.3
Nasehi, A.A.4
Ghoreishi, A.5
Salehi, B.6
-
33
-
-
84867582069
-
Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
-
Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012; 141(2-3):308-14.
-
(2012)
J Affect Disord
, vol.141
, Issue.2-3
, pp. 308-314
-
-
Abbasi, S.H.1
Hosseini, F.2
Modabbernia, A.3
Ashrafi, M.4
Akhondzadeh, S.5
-
34
-
-
33646866333
-
The effects of celecoxib augmentation on cytokine levels in schizophrenia
-
DOI 10.1017/S1461145705005808, PII S1461145705005808
-
Bresee CJ, Delrahim K, Maddux RE, Dolnak D, Ahmadpour O, Rapaport MH. The effects of celecoxib augmentation on cytokine levels in schizophrenia. Int J Neuropsychopharmacol. 2006;9(03):343-8. (Pubitemid 43780502)
-
(2006)
International Journal of Neuropsychopharmacology
, vol.9
, Issue.3
, pp. 343-348
-
-
Bresee, C.J.1
Delrahim, K.2
Maddux, R.E.3
Dolnak, D.4
Ahmadpour, O.5
Rapaport, M.H.6
-
35
-
-
41849105075
-
Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder
-
DOI 10.1097/YCT.0b013e3181571abb, PII 0012450920080300000015
-
Lehtimäki K, Keränen T, Huuhka M, Palmio J, Hurme M, Leinonen E, et al. Increase in plasma proinflammatory cytokines after electroconvulsive therapy in patients with depressive disorder. J ECT. 2008;24(1):88-91. (Pubitemid 351498648)
-
(2008)
Journal of ECT
, vol.24
, Issue.1
, pp. 88-91
-
-
Lehtimaki, K.1
Keranen, T.2
Huuhka, M.3
Palmio, J.4
Hurme, M.5
Leinonen, E.6
Peltola, J.7
-
36
-
-
33846856622
-
C-reactive protein (CRP)-lowering agents
-
DOI 10.1111/j.1527-3466.2006.00033.x
-
Prasad K. C-Reactive Protein (CRP)-Lowering Agents. Cardiovasc Drug Rev. 2006;24(1):33-50. (Pubitemid 46722293)
-
(2006)
Cardiovascular Drug Reviews
, vol.24
, Issue.1
, pp. 33-50
-
-
Prasad, K.1
-
37
-
-
0037469296
-
Selective COX-2 inhibition improves endothelial function in coronary artery disease
-
Chenevard R, Hürlimann D, Béchir M, Enseleit F, Spieker L, Hermann M, et al. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation. 2003;107(3):405-9.
-
(2003)
Circulation
, vol.107
, Issue.3
, pp. 405-409
-
-
Chenevard, R.1
Hürlimann, D.2
Béchir, M.3
Enseleit, F.4
Spieker, L.5
Hermann, M.6
-
38
-
-
0242460486
-
Effect of Cyclooxygenase-2 Inhibition with Rofecoxib on Endothelial Dysfunction and Inflammatory Markers in Patients with Coronary Artery Disease
-
DOI 10.1016/j.jacc.2003.05.006
-
Title LM, Giddens K, McInerney MM, McQueen MJ, Nassar BA. Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease. J Am Coll Cardiol. 2003;42(10):1747-53. (Pubitemid 37433652)
-
(2003)
Journal of the American College of Cardiology
, vol.42
, Issue.10
, pp. 1747-1753
-
-
Title, L.M.1
Giddens, K.2
McInerney, M.M.3
McQueen, M.J.4
Nassar, B.A.5
-
39
-
-
24644475268
-
Effect of celecoxib, a cyclooxygenase-2-specific inhibitor, on insulin sensitivity, C-reactive protein, homocysteine, and metabolic profile in overweight or obese subjects
-
DOI 10.1089/met.2005.3.95
-
González-Ortiz M, Pascoe-González S, Kam-Ramos AM, Hernández-Salazar E. Effect of celecoxib, a cyclooxygenase-2-specific inhibitor, on insulin sensitivity, C-reactive protein, homocysteine, and metabolic profile in overweight or obese subjects. Metab Syndr Relat Disord. 2005;3(2):95-101. (Pubitemid 41269267)
-
(2005)
Metabolic Syndrome and Related Disorders
, vol.3
, Issue.2
, pp. 95-101
-
-
Gonzalez-Ortiz, M.1
Pascoe-Gonzalez, S.2
Martinez-Abundis, E.3
Kam-Ramos, A.M.4
Hernandez-Salazar, E.5
-
40
-
-
84868133575
-
Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: A meta-analysis of randomized controlled trials
-
Tarp S, Bartels EM, Bliddal H, Furst DE, Boers M, Danneskiold- Samsøe B, et al. Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: A meta-analysis of randomized controlled trials. Arthritis Rheum. 2012;64(11):3511-21.
-
(2012)
Arthritis Rheum
, vol.64
, Issue.11
, pp. 3511-3521
-
-
Tarp, S.1
Bartels, E.M.2
Bliddal, H.3
Furst, D.E.4
Boers, M.5
Danneskiold- Samsøe, B.6
|